Monday, April 30, 2012

BMSN - Bio-Matrix Scientific Group Inc.

$BMSN ~ Full Company Profile
Bio-Matrix Scientific Group Inc. - $BMSN

Image

$BMSN is a Fully Transparent OTC.QB and filed their latest 10-Q on April 26, 2012

Highlights Include:

BMSN owns 38% of the estimated $42,182, 649 of Entest BioMedical, Inc through a purchase agreement last year , please see link below of this S-1 .The Mc Donald Animal Hospital Inc., a full service veterinary clinic located in Santa Barbara, California. Also BMSN is pleased to advise that General and Administrative Expenses decreased approximately 24% when compared to the same period ended 2011.

http://www.otcmarkets.com/edgar/GetFili ... ID=8537179 ←-- S-1 for ENTB

Image

Image

Image


$BMSN ~ OverView

Company Web Site: http://www.bmsn.us

$BMSN ~ Bio-Matrix Scientific Group Inc. is a biotechnology research and development company headquartered in San Diego, Ca. with a 15,000 sq. ft. facility that houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.

Bio-Matrix Scientific Group, Inc., a development stage company, through its subsidiary, Entest BioMedical, Inc. (ENTB), focuses on developing and commercializing therapies, medical devices, and medical testing procedures for the veterinary market, as well as on acquiring and operating veterinary clinics.

ENTB’s business model involves acquiring veterinary clinics/hospitals to be utilized as distribution channels for its immuno-therapeutic cancer vaccine for canines (dogs) that is in development stage. Bio-Matrix Scientific Group, Inc. was founded in 2005 and is based in La Mesa, California. Bio-Matrix Scientific Group, Inc. was formerly a subsidiary of BMXP Holdings, Inc.

Bio-Matrix is pursuing relationships with hospitals, medical institutes, research firms, and biotechnology companies to assist in stem cell research, cell culturing, and Regenerative Medicine therapies. Bio-Matrix's facilities are available for processing, culturing, and storage of specimens. Also, under certain situations the Company has laboratories available to organizations conducting research.

Image

Image

$BMSN Subsidiary ~ $ENTB

Image

Company Web Site http://www.entb.net

Entest BioMedical Inc. develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human medicine. Of specific interest to us are immunological vaccines for oncology (cancer vaccines) and veterinary clinic acquisitions.

The basis for the majority of our approaches is underpinned by leveraging the body's own reparative / immunological mechanisms - as opposed to using toxic chemicals.

Areas of Focus:

Currently, Entest is focused on significant therapeutic therapies that show promise for the development of under-served market niches with potential high demand.

Immuno-Therapeutic Cancer Vaccine for Canines (Dog Cancer Vaccine):

The first area of focus involves the development of an immuno-therapeutic cancer vaccine for canines. One in every four dogs will develop some sort of cancer during its lifetime. The Company's goal in this area is to create a treatment that will jumpstart the dog's own immune system to fight cancer, and we have a device that is in development that we believe will be a "game-changer" for canine oncology. With the rollout of our "canines first" approach, Entest feels it can penetrate the veterinary market in the very near term (one to three years) and eventually take this immuno-therapeutic cancer vaccine into human trials once enough paid animal cases support our vaccine's efficacy.

Entest Technologies:

ImenVax (TM)

http://www.entb.net/imenvax.html

Immuno-Therapeutic Cancer Treatment for Canines:

Image

In the encapsulated ImenVax™ device, a “cocktail” of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient’s immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor.

Image

$BMSN ~ Services:

Bio-Matrix’ Research Laboratories and Cryopreservation Facilities:

Microbiology Laboratory features:

FACS Flow Cytometer
Cell Dyn 1800 Hematology Analyzer
Eppendorf Centrifuge
Computype GMP’ Labeling System

Cellular Culture Laboratory features:

Forma Scientific Laminar Flow Hood
Jauan Floor Centrifuge
AXP Cell Separation System – Automated cell separation Closed system for Cord Blood and Peripheral Blood processing
Computype GMP’ Labeling System

Blood Processing Laboratory features:

Forma Scientific Laminar Flow Hood
Jauan Floor Centrifuge
AXP Cell Separation System – Automated cell separation Closed system for Cord Blood and Peripheral Blood processing
Computype GMP’ Labeling System

Image

Adipose Processing Laboratory features:

Class 10,000 20 x 20 Modular Laboratory
Thermo Fisher Scientific Laminar Flow Hood
Jauan Centrifuge
Computype GMP’ Labeling System

Main Laboratory features:

Forma Scientific Laminar Flow Hood
Isotemp Laboratory Refrigerator
Jauan -80 Freezer
Baxter Incubator
Allegra Centrifuge
Isotemp Bath
Fraction Collector
Computype GMP’ Labeling System

Cryogenic Laboratories (2) features:

CBS V-5000 Cryofreezer
CBS 2100 Controlled Rate Freezer
Thermo Scientific 7400 CryoPlus 1 Freezer
Thermo Scientific 744 Cryofreezer
Taylor Wharton 10K Cryofreezer
Alpha Omega Series 1000 Oxygen Monitors (in each Cryo Lab)
MVE Vapor Dry Shipper (2 ea)
Computype GMP’ Labeling System

2 Class 100,000 Research Laboratories (completed).

Image

Specially Designed, Patent Pending Instruments for Harvesting Stem Cells:

The nucleus of Bio-Matrix’s products for development and manufacture are instruments that are specifically designed to provide direct assistance in plastic / cosmetic surgery procedures, as well as for tissue management and stem cell research. To date, the Company has developed approximately 192 diagnostic instruments for these purposes. These lightweight disposable instruments offer the Surgeon the same reliability that they are accustomed to as well as the assurance of no cross-contamination or transfer of disease and will be sold individually or in surgery specific sets. The company will also include the single use device in its Adipose (Fat) Collection Kit for stem cell harvesting.

Image

Image

Image

Bio-Matrix Scientific Group, Inc. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, “BMSN”, and within the OTCQB market tier. As such, Business, Operational, and Financial information on BMSN is fully transparent and available to public view.

Visit: http://www.otcmarkets.com/stock/BMSN/company-info to see complete details.

Market Value: $1,443,795 a/o Apr 27, 2012
A/S : 500 Million per 10-Q filed April 26, 2012
O/S : 85,245,000 per Transfer Agent 4/26/2012

(Please note the share structure posted is what we have gathered, but can change on a daily basis. Please contact the Company or Transfer Agent to get the most current information)

10-Q reported 4/26/2012 for the period ending 3/31/2012:
http://www.otcmarkets.com/edgar/GetFili ... ID=8565516

Incorporated In: DE, USA
Year of Inc.: 2006

Company Notes:

Formerly=Tasco Holdings International, Inc. until 9-06
Formerly=Tasco International, Inc. until 8-05

Transfer Agent:

Securities Transfer Corporation
2591 Dallas Parkway Suite 102
Frisco, Texas 75034

Fax: 469-633-0088
Phone: 469-633-0101
http://www.stctransfer.com

Image

Image

Image

Contact Us:


Bio - Matrix Scientific Group Inc.
8885 Rehco Road
San Diego, California 92122

Website: http://www.bmsn.us

Image

Image

Goodies Newsletter Sign Up:
http://www.stockgoodies.com

Image

Follow Us on Twitter:
http://twitter.com/#!/StockGoodies

Image

Follow StockGoodies Blog:
http://www.stockgoodies.blogspot.com

Image

Follow Us on Facebook:
http://www.facebook.com/groups/STOCKGOODIES

Image

Follow Us on PennyStockTweets:
http://www.pennystocktweets.com/profile/StockGoodies

Image

Disclaimer below:
http://www.http://stockgoodies.blogspot ... aimer.html

Contact Us:
acctadmin@stockgoodies.com

As Always: Our Number 1 Priority is to educate. Penny stocks are very volatile, Always do your own Due Diligence.

Sources: ( http://otcmarkets.com/marketActivity/current-otc-market ) ( http://bloomberg.com ) ( http://finance.yahoo.com ) ( http://businessweek.com )

(these are only sources and not always up to date)